215 related articles for article (PubMed ID: 17433551)
1. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.
Voorzanger-Rousselot N; Garnero P
Cancer Treat Rev; 2007 May; 33(3):230-83. PubMed ID: 17433551
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers of prostate cancer outcome.
Quinn DI; Henshall SM; Sutherland RL
Eur J Cancer; 2005 Apr; 41(6):858-87. PubMed ID: 15808955
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers.
Seleznick MJ
Prim Care; 1992 Dec; 19(4):715-26. PubMed ID: 1281552
[TBL] [Abstract][Full Text] [Related]
4. Biomolecular markers of outcome prediction in prostate cancer.
Lopergolo A; Zaffaroni N
Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial designs for predictive marker validation in cancer treatment trials.
Sargent DJ; Conley BA; Allegra C; Collette L
J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
7. [Problems of tumor progression: doubts or hopes at the turn of the Millennium?].
Tímár J
Orv Hetil; 2000 Apr; 141(17):891-9. PubMed ID: 10827469
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of cytokeratins as tumor markers.
Barak V; Goike H; Panaretakis KW; Einarsson R
Clin Biochem; 2004 Jul; 37(7):529-40. PubMed ID: 15234234
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of total and lipid-bound sialic acid in malignancies].
Cylwik B; Chrostek L; Szmitkowski M
Pol Merkur Lekarski; 2005 Aug; 19(110):237-41. PubMed ID: 16245443
[TBL] [Abstract][Full Text] [Related]
10. Biochemical testing for neuroendocrine tumors.
Vinik AI; Silva MP; Woltering EA; Go VL; Warner R; Caplin M
Pancreas; 2009 Nov; 38(8):876-89. PubMed ID: 19855234
[TBL] [Abstract][Full Text] [Related]
11. Serum tumor markers. Part I: Clinical utility.
Hoefner DM
MLO Med Lab Obs; 2005 Dec; 37(12):20, 22-4. PubMed ID: 16435773
[TBL] [Abstract][Full Text] [Related]
12. [Biomolecular markers in renal adenocarcinoma].
Tejido Sánchez A; Leiva Galvis O
Arch Esp Urol; 2002 May; 55(4):369-81. PubMed ID: 12094483
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and other markers of colon cancer.
Ho SB; Toribara NW; Bresalier RS; Kim YS
Gastroenterol Clin North Am; 1988 Dec; 17(4):811-36. PubMed ID: 3068143
[TBL] [Abstract][Full Text] [Related]
14. [Treatment monitoring, recurrence detection, prognosis. Here's where tumor markers make good sense].
Lamerz R; Stieber P
MMW Fortschr Med; 2002 Oct; 144(41):26-8, 30-2. PubMed ID: 12474357
[TBL] [Abstract][Full Text] [Related]
15. The use of molecular markers of bone turnover in the management of patients with metastatic bone disease.
Seibel MJ
Clin Endocrinol (Oxf); 2008 Jun; 68(6):839-49. PubMed ID: 17980010
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers in staging and prognosis of colorectal carcinoma.
Levy M; Visokai V; Lipska L; Topolcan O
Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for lung cancer: clinical uses.
Greenberg AK; Lee MS
Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
19. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
